Neuburgh Advisers’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$136K Hold
4,268
﹤0.01% 750
2019
Q2
$110K Hold
4,268
﹤0.01% 790
2019
Q1
$108K Hold
4,268
﹤0.01% 780
2018
Q4
$145K Buy
4,268
+176
+4% +$5.72K 0.01% 699
2018
Q3
$146K Buy
4,092
+748
+22% +$26.4K ﹤0.01% 757
2018
Q2
$115K Hold
3,344
﹤0.01% 769
2018
Q1
$113K Hold
3,344
﹤0.01% 769
2017
Q4
$128K Buy
3,344
+506
+18% +$20.2K ﹤0.01% 745
2017
Q3
$106K Buy
2,838
+396
+16% +$14K ﹤0.01% 748
2017
Q2
$91K Buy
2,442
+1,100
+82% +$39.7K ﹤0.01% 752
2017
Q1
$53K Sell
1,342
-22
-2% -$825 ﹤0.01% 751
2016
Q4
$47K Buy
+1,364
New +$53.5K ﹤0.01% 752

Other funds holding NTUS

Neuburgh Advisers's NTUS Position: Q3 2019 in Review

Neuburgh Advisers held its Natus Medical Inc (NTUS) position steady in Q3 2019 at 4,268 shares worth $136K. The position accounts for ﹤0.01% of the portfolio, ranked #750.

Neuburgh Advisers first reported a position in NTUS in Q4 2016 and has held it in 12 quarters since. The position peaked at $146K in Q3 2018. 168 funds tracked by Wall St. Rank hold NTUS as of Q3 2019.

  • Neuburgh Advisers held 4,268 shares of Natus Medical Inc worth $136K as of Q3 2019.
  • Neuburgh Advisers left its Natus Medical Inc share count unchanged in Q3 2019.
  • Natus Medical Inc made up ﹤0.01% of Neuburgh Advisers's portfolio in Q3 2019, its #750 holding.
  • Neuburgh Advisers first reported a position in Natus Medical Inc in Q4 2016 and has held it in 12 quarters since.
  • Neuburgh Advisers's Natus Medical Inc position peaked at $146K in Q3 2018.
  • 168 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.